Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 (SLVO) Price & Performance

Dolby Laboratories, Inc.Trade
Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033Trade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 — how do they compare? Dolby Laboratories, Inc. trades at $49.6 (market cap $4.59B), while Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 trades at $63.45. The key difference: Dolby Laboratories, Inc. pays a 2.91% dividend while Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 pays none. Which is the better fit depends on your goals.

DLBSLVO
Market Cap
$4.59B
Sector
IndustrialsIncome / Options Overlay
52-Week High
$76.79$107.41
52-Week Low
$48.51$62.46
Enterprise Value
$4.04B
Dividend Yield
2.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

Dolby Laboratories (DLB) trades at $49.36, down 0.88% on the day, with a bearish technical outlook. The company maintains strong fundamentals, including a P/E of 19.59, a net income margin of 17.85%, and consistent earnings beats in recent quarters. Recent news highlights include its role in powering immersive audio for the FIFA World Cup 2026 coverage and recognition as a top supplier by General Motors.

The stock presents a value opportunity given its discount to the analyst consensus price target of $87.50, but faces near-term headwinds from bearish technical signals and cyclical end-market exposure. Upside potential hinges on continued licensing growth and execution, while risks include market sentiment and competitive pressures.

Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033

SLVO is trading at $63.72, down 3.21% today amid bearish technical signals with 13 of 13 moving averages indicating sell signals. The stock shows neutral oscillator readings with RSI at 41.10, suggesting neither overbought nor oversold conditions. Key support sits at $63 with resistance at $64. Fundamental data remains limited pending updated financial disclosures.

The technical outlook appears bearish with weak momentum indicators, though current levels near support may provide short-term stability. Investment opportunity hinges on upcoming financial results demonstrating business improvement. Primary risks include lack of recent fundamental visibility and negative technical momentum potentially testing lower support levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB

About Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033

SLVO is an exchange-traded note issued by UBS AG that provides investors with exposure to the performance of a silver-based covered call strategy. The ETN tracks the daily return of the ISE Enhanced 100x Leveraged Silver ETN Index, which combines a long position in silver with a covered call strategy on the silver position. This strategy aims to generate current income from the option premiums, which can provide a buffer during sideways or slightly down markets for silver, but it also caps the potential gains from a significant rise in silver prices. As an ETN, it is subject to the credit risk of the issuer, UBS AG, and has an expiration date of April 21, 2033.

Read more on SLVO